Seguir
Scott Boyer
Scott Boyer
CEO Chemotargets
E-mail confirmado em chemotargets.com
Título
Citado por
Citado por
Ano
Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME
RC Glen, A Bender, CH Arnby, L Carlsson, S Boyer, J Smith
IDrugs 9 (3), 199, 2006
2182006
Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases.
CS Boyer, DR Petersen
Journal of Pharmacology and Experimental Therapeutics 260 (3), 939-946, 1992
1731992
Introducing conformal prediction in predictive modeling. A transparent and flexible alternative to applicability domain determination
U Norinder, L Carlsson, S Boyer, M Eklund
Journal of chemical information and modeling 54 (6), 1596-1603, 2014
1452014
Illuminating drug discovery with biological pathways
G Apic, T Ignjatovic, S Boyer, RB Russell
FEBS letters 579 (8), 1872-1877, 2005
1322005
A crowdsourcing evaluation of the NIH chemical probes
TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ...
Nature chemical biology 5 (7), 441-447, 2009
1232009
Reaction site mapping of xenobiotic biotransformations
S Boyer, CH Arnby, L Carlsson, J Smith, V Stein, RC Glen
Journal of chemical information and modeling 47 (2), 583-590, 2007
1212007
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities
A Sutter, A Amberg, S Boyer, A Brigo, JF Contrera, LL Custer, KL Dobo, ...
Regulatory Toxicology and Pharmacology 67 (1), 39-52, 2013
1192013
Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data
CL Gavaghan, CH Arnby, N Blomberg, G Strandlund, S Boyer
Journal of computer-aided molecular design 21 (4), 189-206, 2007
1072007
Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats
AV Turnbull, L Ellershaw, DJ Masters, S Birtles, S Boyer, D Carroll, ...
Diabetes 51 (8), 2441-2449, 2002
1032002
In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine
AC Egnell, B Houston, S Boyer
Journal of Pharmacology and Experimental Therapeutics 305 (3), 1251-1262, 2003
982003
Ligand-based approach to in silico pharmacology: nuclear receptor profiling
J Mestres, L Martín-Couce, E Gregori-Puigjané, M Cases, S Boyer
Journal of chemical information and modeling 46 (6), 2725-2736, 2006
912006
Evidence for the activation of the signal-responsive phospholipase A2 by exogenous hydrogen peroxide
CS Boyer, GL Bannenberg, EPA Neve, Å Ryrfeldt, P Moldéus
Biochemical pharmacology 50 (6), 753-761, 1995
911995
Choosing feature selection and learning algorithms in QSAR
M Eklund, U Norinder, S Boyer, L Carlsson
Journal of Chemical Information and Modeling 54 (3), 837-843, 2014
882014
Use of historic metabolic biotransformation data as a means of anticipating metabolic sites using MetaPrint2D and Bioclipse
L Carlsson, O Spjuth, S Adams, RC Glen, S Boyer
BMC bioinformatics 11 (1), 1-7, 2010
862010
Potentiation of cocaine‐mediated hepatotoxicity by acute and chronic ethanol
CS Boyer, DR Petersen
Alcoholism: Clinical and Experimental Research 14 (1), 28-31, 1990
851990
Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity
MH Block, S Boyer, W Brailsford, DR Brittain, D Carroll, S Chapman, ...
Journal of medicinal chemistry 45 (16), 3509-3523, 2002
842002
CoMPARA: collaborative modeling project for androgen receptor activity
K Mansouri, N Kleinstreuer, AM Abdelaziz, D Alberga, VM Alves, ...
Environmental health perspectives 128 (2), 027002, 2020
822020
New methods in predictive metabolism
S Boyer, I Zamora
Journal of computer-aided molecular design 16 (5), 403-413, 2002
792002
Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models
MP Gleeson, AM Davis, KK Chohan, SW Paine, S Boyer, CL Gavaghan, ...
Journal of computer-aided molecular design 21 (10), 559-573, 2007
742007
Behavioural toxicity assessment of silver ions and nanoparticles on zebrafish using a locomotion profiling approach
G Ašmonaitė, S Boyer, KB de Souza, B Wassmur, J Sturve
Aquatic Toxicology 173, 143-153, 2016
682016
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20